2,587
Views
493
CrossRef citations to date
0
Altmetric
New Drugs

Development of the Proteasome Inhibitor Velcade™ (Bortezomib)

, Ph.D. & , Ph.D. , M.D.
Pages 304-311 | Published online: 24 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (25)

Mehreen Ghufran, Ashfaq Ur Rehman, Muhammad Ayaz, Zaheer ul-Haq, Reaz Uddin, Syed Sikander Azam & Abdul Wadood. (2023) New lead compounds identification against KRas mediated cancers through pharmacophore-based virtual screening and in vitro assays. Journal of Biomolecular Structure and Dynamics 41:16, pages 8053-8067.
Read now
Mohammad Mahmoudian, Hadi Valizadeh & Parvin Zakeri-Milani. (2018) Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation. Drug Development and Industrial Pharmacy 44:10, pages 1598-1605.
Read now
Princy Gupta & Aman Mahajan. (2017) Shades of chemical beauty: An overview of synthetic routes to some anticancer drugs. Synthetic Communications 47:16, pages 1415-1433.
Read now
Maja Marasovic, Sinisa Ivankovic, Ranko Stojkovic, Damir Djermic, Borivoj Galic & Mladen Milos. (2017) In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 1299-1304.
Read now
Pan Xu, Guang Hu, Cheng Luo & Zhongjie Liang. (2016) DNA methyltransferase inhibitors: an updated patent review (2012-2015). Expert Opinion on Therapeutic Patents 26:9, pages 1017-1030.
Read now
Scott P Kenney & Xiang-Jin Meng. (2015) Therapeutic targets for the treatment of hepatitis E virus infection. Expert Opinion on Therapeutic Targets 19:9, pages 1245-1260.
Read now
Sinisa Ivankovic, Ranko Stojkovic, Zoran Galic, Borivoj Galic, Jelena Ostojic, Maja Marasovic & Mladen Milos. (2015) In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]). Journal of Enzyme Inhibition and Medicinal Chemistry 30:3, pages 354-359.
Read now
Maria Cekanova & Kusum Rathore. (2014) Animal models and therapeutic molecular targets of cancer: utility and limitations. Drug Design, Development and Therapy 8, pages 1911-1922.
Read now
Cristina Meregalli, Alessia Chiorazzi, Valentina A Carozzi, Annalisa Canta, Barbara Sala, Matteo Colombo, Norberto Oggioni, Cecilia Ceresa, Dana Foudah, Federica La Russa, Mariarosaria Miloso, Gabriella Nicolini, Paola Marmiroli, David LH Bennett & Guido Cavaletti. (2014) Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy. Cell Cycle 13:4, pages 612-621.
Read now
Sagar Lonial, Jonathan Kaufman, Jacob Laubach & Paul Richardson. (2013) Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myeloma. Expert Opinion on Biological Therapy 13:12, pages 1731-1740.
Read now
Taylan Turan, Gülşah Şanlı-Mohamed & Yusuf Baran. (2013) Changes in protein profiles of multiple myeloma cells in response to bortezomib. Leukemia & Lymphoma 54:5, pages 1061-1068.
Read now
Rashid Z Khan & Ashraf Badros. (2012) Role of carfilzomib in the treatment of multiple myeloma. Expert Review of Hematology 5:4, pages 361-372.
Read now
Bulbul Pandit & Andrei L. Gartel. (2011) Proteasome inhibitors suppress expression of NPM and ARF proteins. Cell Cycle 10:22, pages 3827-3829.
Read now
Fernando Roncolato, Anna Gazzola, Pier Luigi Zinzani, Stefano A Pileri & Pier Paolo Piccaluga. (2011) Targeted molecular therapy in peripheral T-cell lymphomas. Expert Review of Hematology 4:5, pages 551-562.
Read now
Lapo Alinari, Valerie L. White, Christian T. Earl, Timothy P. Ryan, Jeffrey S. Johnston, James T. Dalton, Amy K. Ferketich, Raymond Lai, David M. Lucas, Pierluigi Porcu, Kristie A. Blum, John C. Byrd & Robert A. Baiocchi. (2009) Combination bortezomib and rituximab treatment affects multiple survival and death pathways to promote apoptosis in mantle cell lymphoma. mAbs 1:1, pages 31-40.
Read now
Ibrahim Sadek, Angela Dispenzieri, Morie A. Gertz & Shaji Kumar. (2009) Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma. Leukemia & Lymphoma 50:6, pages 1033-1035.
Read now
NagiB. Kumar, JeffreyP. Krischer, Kathy Allen, Diane Riccardi, Karen Besterman-Dahan, Raoul Salup, Lovellen Kang, Ping Xu & Julio Pow-Sang. (2007) Safety of Purified Isoflavones in Men With Clinically Localized Prostate Cancer. Nutrition and Cancer 59:2, pages 169-175.
Read now
Kim Newton & Domagoj Vucic. (2007) Ubiquitin Ligases in Cancer: Ushers for Degradation. Cancer Investigation 25:6, pages 502-513.
Read now
Jean-Michel Dayer, Nicolas Molnarfi & Danielle Burger. (2005) From cellular receptors to transduction–transcription pathways for cytokines: at which level should the inhibition be targeted in inflammation?. Expert Opinion on Biological Therapy 5:sup1, pages S83-S96.
Read now
K K Jain. (2005) Personalised medicine for cancer: from drug development into clinical practice. Expert Opinion on Pharmacotherapy 6:9, pages 1463-1476.
Read now
Patricia P Klinger & Ulrich Schubert. (2005) The ubiquitin–proteasome system in HIV replication: potential targets for antiretroviral therapy. Expert Review of Anti-infective Therapy 3:1, pages 61-79.
Read now
E.A Sausville. (2004) Target Selection Issues in Drug Discovery and Development. Journal of Chemotherapy 16:sup4, pages 16-18.
Read now

Articles from other publishers (468)

Yu Miyajima, Tomomi Noguchi-Yachide, Kotaro Ochiai & Shinya Fujii. (2024) Physicochemical characterization of B -hydroxyphenyl phosphine borane derivatives and their evaluation as nuclear estrogen receptor ligands . RSC Medicinal Chemistry.
Crossref
Jared M. Sprague, Ajay S. Yekkirala, Bhagat Singh, Ivan Tochitsky, Michael Stephens, Octavio Viramontes, Jelena Ivanis, Natalia P. Biscola, Leif A. Havton, Clifford J. Woolf & Alban Latremoliere. (2023) Bortezomib-induced neuropathy is in part mediated by the sensitization of TRPV1 channels. Communications Biology 6:1.
Crossref
Betsegaw Lemma, Di Zhang, Ganga B. Vamisetti, Bryan G. Wentz, Hiroaki Suga, Ashraf Brik, Jacek Lubkowski & David Fushman. (2023) Mechanism of selective recognition of Lys48-linked polyubiquitin by macrocyclic peptide inhibitors of proteasomal degradation. Nature Communications 14:1.
Crossref
Guo-Qing Chen, Hong-Yan Guo, Zhe-Shan Quan, Qing-Kun Shen, Xiaoting Li & Tian Luan. (2023) Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry. Molecules 28:21, pages 7440.
Crossref
Keiichi Hirano & Masanobu Uchiyama. (2023) Synthetic Element Chemistry based on Precise Designs of Reagents and Transition States. Journal of Synthetic Organic Chemistry, Japan 81:11, pages 1096-1102.
Crossref
Joanna Krajewska, Piotr Chyży, Krzysztof Durka, Patrycja Wińska, Krystiana A. Krzyśko, Sergiusz Luliński & Agnieszka E. Laudy. (2023) Aromatic Diboronic Acids as Effective KPC/AmpC Inhibitors. Molecules 28:21, pages 7362.
Crossref
Silke Geurs, Dorien Clarisse, Karolien De Bosscher & Matthias D’hooghe. (2023) The Zinc-Binding Group Effect: Lessons from Non-Hydroxamic Acid Vorinostat Analogs. Journal of Medicinal Chemistry 66:12, pages 7698-7729.
Crossref
Mengyuan Hou, Yahao Wang, Puhui Li, Xingxing Ma, Guan Zhang & Qiuling Song. (2023) Divergent Synthesis of 1,1-Carbonyl Amino Alkyl Borons from Indoles. Organic Letters 25:22, pages 4038-4043.
Crossref
Jyoti Goutam, Gunjan Sharma, Vandana Yadav, Gauri Pathak, Ravindra Nath Kharwar & Divakar Sharma. (2023) A Focused Review of the Pharmacological Potentials of Terrein as an Anticancer Agent. Natural Product Communications 18:5, pages 1934578X2311741.
Crossref
Julia Adler, Roni Oren & Yosef Shaul. (2023) Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy . Cancer Medicine 12:9, pages 10781-10790.
Crossref
Sepideh Valimehr, Ashish Sethi, Manjari Shukla, Sudipta Bhattacharyya, Mohsen Kazemi & Isabelle Rouiller. (2023) Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases. Biomolecules 13:5, pages 737.
Crossref
Laura Talavera, Robert R. A. Freund, Huihui Zhang, Matthew Wakeling, Mara Jensen & Ruben Martin. (2023) Nickel-Catalyzed 1,1-Aminoborylation of Unactivated Terminal Alkenes. ACS Catalysis 13:8, pages 5538-5543.
Crossref
Patrick Müller, Mergim Meta, Jan Laurenz Meidner, Marvin Schwickert, Jessica Meyr, Kevin Schwickert, Christian Kersten, Collin Zimmer, Stefan Josef Hammerschmidt, Ariane Frey, Albin Lahu, Sergio de la Hoz-Rodríguez, Laura Agost-Beltrán, Santiago Rodríguez, Kira Diemer, Wilhelm Neumann, Florenci V. Gonzàlez, Bernd Engels & Tanja Schirmeister. (2023) Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study. International Journal of Molecular Sciences 24:8, pages 7226.
Crossref
Elma Mons, Robbert Q. Kim & Monique P. C. Mulder. (2023) Technologies for Direct Detection of Covalent Protein–Drug Adducts. Pharmaceuticals 16:4, pages 547.
Crossref
Rutwika S. Thete, Shahriar Roushani, Faiyaz K. Shaikh, Jyoti Kulkarni & Raghavendra H. L. (2023) Isolation and Characterization of Protease Inhibitors with Antimicrobial Activity from Sirisa (Albizia lebbeck) Seed Protein Extract. Biosciences Biotechnology Research Asia 20:1, pages 85-95.
Crossref
Qian‐Wei Luo, Lu Yao, Ling Li, Zhuo Yang, Mei‐Mei Zhao, Yong‐Zhe Zheng, Fang‐Fang Zhuo, Ting‐Ting Liu, Xiao‐Wen Zhang, Dan Liu, Peng‐Fei Tu & Ke‐Wu Zeng. (2022) Inherent Capability of Self‐Assembling Nanostructures in Specific Proteasome Activation for Cancer Cell Pyroptosis. Small 19:9.
Crossref
Nastaran Karimi & Seyed Javad Moghaddam. (2023) KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions. Cells 12:5, pages 749.
Crossref
Giuseppe Zuccarello, Suzanne M. Batiste, Hyungdo Cho & Gregory C. Fu. (2023) Enantioselective Synthesis of α-Aminoboronic Acid Derivatives via Copper-Catalyzed N-Alkylation. Journal of the American Chemical Society 145:6, pages 3330-3334.
Crossref
Brad Hocking, Alan Armstrong & David J. Mann. 2023. 105 146 .
Alexander A. Braddock, Grace E. Lee, Emmanuel A. Theodorakis & Erik A. Romero. (2022) Interrogating Redox and Lewis Base Activations of Aminoboranes. Organometallics 41:24, pages 3845-3851.
Crossref
Carlos Vela-Rodríguez & Lari Lehtiö. (2022) Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer. Biochemical Society Transactions 50:6, pages 1683-1692.
Crossref
Shan-Shan Zhao, Xiao-Lei Su, Rong-Jia Pan, Li-Qun Lu, Guo-Dong Zheng & Shu-Ming Zou. (2022) The transcriptomic responses of blunt snout bream (Megalobrama amblycephala) to acute hypoxia stress alone, and in combination with bortezomib. BMC Genomics 23:1.
Crossref
Naoya Kondo, Erika Aoki, Shinya Takada & Takashi Temma. (2022) A Red-Emitting Fluorescence Sensor for Detecting Boronic Acid-Containing Agents in Cells. Sensors 22:19, pages 7671.
Crossref
Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Irene Attucci, Ludovica Pengue, Raffaella Cassano Cassano, Francesco Ghio, Enrico Orciuolo, Martina Simoncelli, Monica Bocchia, Sara Galimberti & Gabriele Buda. (2022) Carfilzomib plus dexamethasone in patients with relapsed and refractory multiple myeloma: A retro‐prospective observational study. European Journal of Haematology 109:4, pages 373-380.
Crossref
Xianquan Zhan, Miaolong Lu, Lamei Yang, Jingru Yang, Xiaohan Zhan, Shu Zheng, Yuna Guo, Biao Li, Siqi Wen, Jiajia Li & Na Li. (2022) Ubiquitination-mediated molecular pathway alterations in human lung squamous cell carcinomas identified by quantitative ubiquitinomics. Frontiers in Endocrinology 13.
Crossref
Ofelia Hernández-Negrete, Rogerio R. Sotelo-Mundo, Hilda E. Esparza-Ponce, Martín A. Encinas-Romero & Javier Hernández-Paredes. (2022) New hydrate cocrystal of l-proline with 4-acetylphenylboronic acid obtained via mechanochemistry and solvent evaporation: An experimental and theoretical study. Journal of Solid State Chemistry 313, pages 123282.
Crossref
Jiranan Chotitumnavee, Yasunobu Yamashita, Yukari Takahashi, Yuri Takada, Tetsuya Iida, Makoto Oba, Yukihiro Itoh & Takayoshi Suzuki. (2022) Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC). Chemical Communications 58:29, pages 4635-4638.
Crossref
Conor Horgan & Timothy P. O’Sullivan. (2022) Recent Developments in the Practical Application of Novel Carboxylic Acid Bioisosteres. Current Medicinal Chemistry 29:13, pages 2203-2234.
Crossref
Jianguo Tao, Venkat Srinivasan, Xiangjiao Yi, Yingchun Zhao, Hengwei Zhang, Xi Lin, Xichao Zhou, Brendan F Boyce, Peter W Villalta, Frank H Ebetino, Koc Kan Ho, Robert K BoeckmanJrJr & Lianping Xing. (2022) Bone‐Targeted Bortezomib Inhibits Bortezomib‐Resistant Multiple Myeloma in Mice by Providing Higher Levels of Bortezomib in Bone . Journal of Bone and Mineral Research 37:4, pages 629-642.
Crossref
Barbara Kaltschmidt, Kaya E. Witte, Johannes F. W. Greiner, Florian Weissinger & Christian Kaltschmidt. (2022) Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. Biomedicines 10:2, pages 261.
Crossref
Zhenya Li, Ronghua Xu, Huichuang Guo, He Yang, Guangqing Xu, Enxue Shi, Junhua Xiao & Wenjun Tang. (2022) Enantioselective Rhodium-Catalyzed Hydrogenation of ( Z )- N -Sulfonyl-α-dehydroamido Boronic Esters . Organic Letters 24:2, pages 714-719.
Crossref
Marta Domżalska, Aleksandra M. Dąbrowska, Dawid Chojnowski, Mariusz Makowski & Agnieszka Chylewska. (2022) Sensors to the Diagnostic Assessment of Anticancer and Antimicrobial Therapies Effectiveness by Drugs a with Pyrazine Scaffold. Chemosensors 10:1, pages 24.
Crossref
Robert S. Foti. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 716 742 .
Kieren J. Evans, Paul A. Morton, Christian Luz, Callum Miller, Olivia Raine, Jason M. Lynam & Stephen M. Mansell. (2021) Rhodium Indenyl NHC and Fluorenyl‐Tethered NHC Half‐Sandwich Complexes: Synthesis, Structures and Applications in the Catalytic C−H Borylation of Arenes and Alkanes. Chemistry – A European Journal 27:71, pages 17824-17833.
Crossref
Hong-Bing Liu, Jack R. Davison, Rahim Rajwani, Gengxiang Zhao, Shannon I. Ohlemacher, Robert D. O’Connor & Carole A. Bewley. (2021) Lentzeacins A-E, New Bacterial-Derived 2,5- and 2,6-Disubstituted Pyrazines from a BGC-Rich Soil Bacterium Lentzea sp. GA3-008. Molecules 26:23, pages 7197.
Crossref
Aditya Rayasam & William R. Drobyski. (2021) Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease. Frontiers in Immunology 12.
Crossref
Ofelia Hernández-Negrete, Rogerio R. Sotelo-Mundo, Hilda E. Esparza-Ponce & Javier Hernández-Paredes. (2021) Molecular structure, covalent and non-covalent interactions of an oxaborole derivative (L-PRO2F3PBA): FTIR, X-ray diffraction and QTAIM approach. Journal of Molecular Structure 1243, pages 130911.
Crossref
Ertan Kanbur, Ahmet Tarık Baykal & Azmi Yerlikaya. (2021) Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line. Medical Oncology 38:9.
Crossref
Masoom Raza, Naveen Kumar, Uttara Nair, Gehna Luthra, Ushosi Bhattacharyya, Smruthi Jayasundar, Rama Jayasundar & Seema Sehrawat. (2021) Current updates on precision therapy for breast cancer associated brain metastasis: Emphasis on combination therapy. Molecular and Cellular Biochemistry 476:9, pages 3271-3284.
Crossref
Hector NewmanAlen Krajnc, Dom BelliniCharles J. Eyermann, Grant A. Boyle, Neil G. PatersonKatherine E. McAuleyRobert LesniakMukesh Gangar, Frank von Delft, Jürgen Brem, Kelly Chibale, Christopher J. Schofield & Christopher G. Dowson. (2021) High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes. Journal of Medicinal Chemistry 64:15, pages 11379-11394.
Crossref
Kayhan Mehdizadeh, Farangis Ataei & Saman Hosseinkhani. (2021) Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel. Medical Oncology 38:6.
Crossref
Lei Zhong, Yueshan Li, Liang Xiong, Wenjing Wang, Ming Wu, Ting Yuan, Wei Yang, Chenyu Tian, Zhuang Miao, Tianqi Wang & Shengyong Yang. (2021) Small molecules in targeted cancer therapy: advances, challenges, and future perspectives. Signal Transduction and Targeted Therapy 6:1.
Crossref
Mahadev L. Shegavi, Suresh Saini, Ramesh Bhawar, Meghana Desai Vishwantha & Shubhankar Kumar Bose. (2021) Recyclable Copper Nanoparticles‐Catalyzed Hydroboration of Alkenes and β‐Borylation of α,β‐Unsaturated Carbonyl Compounds with Bis(Pinacolato)Diboron. Advanced Synthesis & Catalysis 363:9, pages 2408-2416.
Crossref
Xiangyu Li & Dennis G. Hall. (2020) Synthesis and Applications of β‐Aminoalkylboronic Acid Derivatives. Advanced Synthesis & Catalysis 363:9, pages 2209-2223.
Crossref
Jon Uranga, Lukas Hasecke, Jonny Proppe, Jan Fingerhut & Ricardo A. Mata. (2021) Theoretical Studies of the Acid–Base Equilibria in a Model Active Site of the Human 20S Proteasome. Journal of Chemical Information and Modeling 61:4, pages 1942-1953.
Crossref
Gil-Soon Choi, Ho Sup Lee & Hee-Kyoo Kim. (2021) A case of bortezomib (Velcade)–induced Stevens-Johnson syndrome confirmed by patch test. Asia Pacific Allergy 11:2.
Crossref
Antonio Lopalco, Rosa Maria Iacobazzi, Nunzio Denora & Valentino J. Stella. (2021) Bortezomib Aqueous Solubility in the Presence and Absence of D-Mannitol: A Clarification With Formulation Implications. Journal of Pharmaceutical Sciences 110:1, pages 543-547.
Crossref
Lloyd D. Fricker. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1288 1292 .
Lloyd D. Fricker. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology 1 5 .
Xianquan Zhan & Miaolong Lu. 2020. Ubiquitin - Proteasome Pathway. Ubiquitin - Proteasome Pathway.
Amanda L. Huff, Laura Evgin, Jill Thompson, Tim Kottke, Christopher B. Driscoll, Jason Tonne, Phonphimon Wongthida, Matthew Schuelke, Kevin G. Shim, Georges Mer, Marina Ramirez-Alvarado & Richard Vile. (2020) Vesicular Stomatitis Virus Encoding a Destabilized Tumor Antigen Improves Activation of Anti-tumor T Cell Responses. Molecular Therapy 28:12, pages 2540-2552.
Crossref
Cinzia Federico, Kinan Alhallak, Jennifer Sun, Kathleen Duncan, Feda Azab, Gail P. Sudlow, Pilar de la Puente, Barbara Muz, Vaishali Kapoor, Luna Zhang, Fangzheng Yuan, Matea Markovic, Joseph Kotsybar, Katherine Wasden, Nicole Guenthner, Shannon Gurley, Justin King, Daniel Kohnen, Noha N. Salama, Dinesh Thotala, Dennis E. Hallahan, Ravi Vij, John F. DiPersio, Samuel Achilefu & Abdel Kareem Azab. (2020) Tumor microenvironment-targeted nanoparticles loaded with bortezomib and ROCK inhibitor improve efficacy in multiple myeloma. Nature Communications 11:1.
Crossref
Yajing Liu, Sahezeel Awadia, Amy Delaney, Merna Sitto, Carl G. Engelke, Heli Patel, Andrew Calcaterra, Sylvia Zelenka-Wang, Hojin Lee, Joseph Contessa, Nouri Neamati, Mats Ljungman, Theodore S. Lawrence, Meredith A. Morgan & Alnawaz Rehemtulla. (2020) UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer. Translational Oncology 13:11, pages 100834.
Crossref
Banafsheh Mirzaei-Seresht, Masood Bazrgar, Masoud Sheidai, Seyedeh-Nafiseh Hassani, Najmeh Sadat Masoudi & Sepideh Mollammohammadi. (2020) Chromosomal instability reducing effect of paclitaxel and lapatinib in mouse embryonic stem cells with chromosomal abnormality. Molecular Biology Reports 47:11, pages 8605-8614.
Crossref
Lujia Mao & Shubhankar Kumar Bose. (2020) Hydroboration of Enynes and Mechanistic Insights. Advanced Synthesis & Catalysis 362:20, pages 4174-4188.
Crossref
Breanna L. Zerfas, Rachel A. Coleman, Andres F. Salazar-Chaparro, Nathaniel J. Macatangay & Darci J. Trader. (2020) Fluorescent Probes with Unnatural Amino Acids to Monitor Proteasome Activity in Real-Time. ACS Chemical Biology 15:9, pages 2588-2596.
Crossref
Antonio Lopalco, Angela A. Lopedota, Valentino Laquintana, Nunzio Denora & Valentino J. Stella. (2020) Boric Acid, a Lewis Acid With Unique and Unusual Properties: Formulation Implications. Journal of Pharmaceutical Sciences 109:8, pages 2375-2386.
Crossref
Matt Guest, Richard Le Sueur, Melanie Pilkington & Travis Dudding. (2020) Development of an Unsymmetrical Cyclopropenimine‐Guanidine Platform for Accessing Strongly Basic Proton Sponges and Boron‐Difluoride Diaminonaphthalene Fluorophores. Chemistry – A European Journal 26:39, pages 8608-8620.
Crossref
Yuki Yoshimatsu, Rei Noguchi, Ryuto Tsuchiya, Akane Sei, Jun Sugaya, Shintaro Iwata, Akihiko Yoshida, Akira Kawai & Tadashi Kondo. (2020) Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Human Cell 33:3, pages 877-885.
Crossref
Martien A. Würdemann, Cristina Niţu, Stefaan M. A. De Wildeman, Katrien V. Bernaerts & Romano V. A. Orru. (2020) The Forgotten Pyrazines: Exploring the Dakin–West Reaction. Chemistry – A European Journal 26:36, pages 8090-8100.
Crossref
Giuseppe Sferrazzo, Michelino Di Rosa, Eugenio Barone, Giovanni Li Volti, Nicolò Musso, Daniele Tibullo & Ignazio Barbagallo. (2020) Heme Oxygenase-1 in Central Nervous System Malignancies. Journal of Clinical Medicine 9:5, pages 1562.
Crossref
Hiroaki Kimura. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 9 .
Shinji Iwasaki, Andy Zhu, Michael Hanley, Karthik Venkatakrishnan & Cindy Xia. (2020) A Translational Physiologically Based Pharmacokinetics/Pharmacodynamics Framework of Target-Mediated Disposition, Target Inhibition and Drug–Drug Interactions of Bortezomib. The AAPS Journal 22:3.
Crossref
Marcin Poreba. (2020) Protease‐activated prodrugs: strategies, challenges, and future directions. The FEBS Journal 287:10, pages 1936-1969.
Crossref
Nozomi Arakawa, Kazunori Nagao, Ryo Murakami, Yuto Sumida, Hiroshi Arakawa, Fuyuhiko Inagaki & Hirohisa Ohmiya. (2020) Aliphatic Oxaboroles Enabling Remarkable Recognition of Diols. Bulletin of the Chemical Society of Japan 93:4, pages 576-580.
Crossref
Shenq‐Shyang Huang, Li‐Jin Hsu & Nan‐Shan Chang. (2020) Functional role of WW domain‐containing proteins in tumor biology and diseases: Insight into the role in ubiquitin‐proteasome system. FASEB BioAdvances 2:4, pages 234-253.
Crossref
Debangana Chakravorty, Abhirupa Ghosh & Sudipto Saha. (2020) Computational approach to target USP28 for regulating Myc. Computational Biology and Chemistry 85, pages 107208.
Crossref
Zongsheng Duan, Jian Zhang, Jing Li, Xiaochuan Pang & Hushan Wang. (2020) Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation. Frontiers in Oncology 10.
Crossref
Marta L. Mendes, Miriam R. Fougeras & Gunnar Dittmar. (2020) Analysis of ubiquitin signaling and chain topology cross-talk. Journal of Proteomics 215, pages 103634.
Crossref
Miaolong Lu, Wei Chen, Wei Zhuang & Xianquan Zhan. (2020) Label-free quantitative identification of abnormally ubiquitinated proteins as useful biomarkers for human lung squamous cell carcinomas. EPMA Journal 11:1, pages 73-94.
Crossref
Karolina Łuczkowska, Dorota Rogińska, Zofia Ulańczyk & Bogusław Machaliński. (2020) Effect of Bortezomib on Global Gene Expression in PC12-Derived Nerve Cells. International Journal of Molecular Sciences 21:3, pages 751.
Crossref
Yazhou Lou, Jun Wang, Gelin Gong, Fanfu Guan, Jiaxiang Lu, Jialin Wen & Xumu Zhang. (2020) Catalytic asymmetric hydrogenation of ( Z )-α-dehydroamido boronate esters: direct route to alkyl-substituted α-amidoboronic esters . Chemical Science 11:3, pages 851-855.
Crossref
Ronald L. Reyes, Miyu Sato, Tomohiro Iwai & Masaya Sawamura. (2019) Asymmetric Synthesis of α-Aminoboronates via Rhodium-Catalyzed Enantioselective C(sp 3 )–H Borylation . Journal of the American Chemical Society 142:1, pages 589-597.
Crossref
Lloyd D. Fricker. (2020) Proteasome Inhibitor Drugs. Annual Review of Pharmacology and Toxicology 60:1, pages 457-476.
Crossref
G. Ramesh, N.M. Sharath Kumar, P. Raghavendra Kumar, P.A. Suchetan, S. Devaraja, Foro Sabine & G. Nagaraju. (2020) Synthesis, characterisation, crystal structures, anticoagulant and antiplatelet activity studies of new 2,6-dipyrazinylpyridines with pendant trimethoxyphenyl. Journal of Molecular Structure 1200, pages 127040.
Crossref
Yu Zhong Peng, Li Jun Yang, Hang Hong Lo, Betty Yuen Kwan Law & Vincent Kam Wai Wong. 2020. New Nanomaterials and Techniques for Tumor-targeted Systems. New Nanomaterials and Techniques for Tumor-targeted Systems 135 229 .
Qi Wang, Fang Jiang & Gaosi Xu. (2019) The pathogenesis of renal injury and treatment in light chain deposition disease. Journal of Translational Medicine 17:1.
Crossref
Sho Nakai, Shutaro Yamada, Hidetatsu Outani, Takaaki Nakai, Naohiro Yasuda, Hirokazu Mae, Yoshinori Imura, Toru Wakamatsu, Hironari Tamiya, Takaaki Tanaka, Kenichiro Hamada, Akiyoshi Tani, Akira Myoui, Nobuhito Araki, Takafumi Ueda, Hideki Yoshikawa, Satoshi Takenaka & Norifumi Naka. (2019) Establishment of a novel human CIC-DUX4 sarcoma cell line, Kitra-SRS, with autocrine IGF-1R activation and metastatic potential to the lungs. Scientific Reports 9:1.
Crossref
Ye-Ryung Kim, Eun-Ji Lee, Kyong-Oh Shin, Min Hee Kim, Yael Pewzner-Jung, Yong-Moon Lee, Joo-Won Park, Anthony H. Futerman & Woo-Jae Park. (2019) Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases. Experimental & Molecular Medicine 51:11, pages 1-16.
Crossref
Suzannah J. Rihn, Muhamad Afiq Aziz, Douglas G. Stewart, Joseph Hughes, Matthew L. Turnbull, Mariana Varela, Elena Sugrue, Christie S. Herd, Megan Stanifer, Steven P. Sinkins, Massimo Palmarini & Sam J. Wilson. (2019) TRIM69 Inhibits Vesicular Stomatitis Indiana Virus. Journal of Virology 93:20.
Crossref
G. J. J. KierkelsW. ScheperA. D. MeringaI. JohannaD. X. BeringerA. JanssenM. SchifflerT. Aarts-RiemensL. KramerT. StraetemansS. HeijhuursJ. H. W. Leusen, E. San José, K. FuchsM. GriffioenJ. H. FalkenburgL. Bongiovanni, A. de BruinD. Vargas-DiazM. Altelaar, A. J. R. Heck, L. D. ShultzF. Ishikawa, M. I. Nishimura, Z. SebestyénJ. Kuball. (2019) Identification of a tumor-specific allo-HLA–restricted γδTCR. Blood Advances 3:19, pages 2870-2882.
Crossref
Sihua Liu, Hongyun Liu, Keke Zhang, Xueping Li, Yuqin Duan, Zhiyun Wang & Tao Wang. (2019) Proteasome Inhibitor PS-341 Effectively Blocks Infection by the Severe Fever with Thrombocytopenia Syndrome Virus. Virologica Sinica 34:5, pages 572-582.
Crossref
Sravanthi Shastri, Bhaswati Chatterjee & Suman S. Thakur. (2019) Achievements in Cancer Research and its Therapeutics in Hundred Years. Current Topics in Medicinal Chemistry 19:17, pages 1545-1562.
Crossref
Wei-Nung Liu, Chao-Feng Chang, Chi-Hsiang Chung, Wu-Chien Chien, Tzu-Chuan Huang, Yi-Ying Wu, Ching-Liang Ho & Jia-Hong Chen. (2019) Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis. PLOS ONE 14:9, pages e0222522.
Crossref
Lang, Guerrero-Giménez, Prince, Ackerman, Bonorino & Calderwood. (2019) Heat Shock Proteins Are Essential Components in Transformation and Tumor Progression: Cancer Cell Intrinsic Pathways and Beyond. International Journal of Molecular Sciences 20:18, pages 4507.
Crossref
Nechama Gilad, Hila Zukerman, Marjorie Pick & Moshe E. Gatt. (2019) The role of CD24 in multiple myeloma tumorigenicity and effects of the microenvironment on its expression. Oncotarget 10:52, pages 5480-5491.
Crossref
Vishal Das, Sourya Bhattacharya, Channakeshavaiah Chikkaputtaiah, Saugata Hazra & Mintu Pal. (2019) The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective. Journal of Cellular Physiology 234:9, pages 14535-14555.
Crossref
Shengzhang Dong, Seokyoung Kang & George Dimopoulos. (2019) Identification of anti-flaviviral drugs with mosquitocidal and anti-Zika virus activity in Aedes aegypti. PLOS Neglected Tropical Diseases 13:8, pages e0007681.
Crossref
Kristine Senkane, Ekaterina V. Vinogradova, Radu M. Suciu, Vincent M. Crowley, Balyn W. Zaro, J. Michael Bradshaw, Ken A. Brameld & Benjamin F. Cravatt. (2019) The Proteome‐Wide Potential for Reversible Covalency at Cysteine. Angewandte Chemie International Edition 58:33, pages 11385-11389.
Crossref
Ramiro Eugenio Cárdenas-Gonzalez, Maira Elizabeth Herz Ruelas & Jorge Ocampo Candiani. (2019) Lichen myxedematosus: a rare group of cutaneous mucinosis. Anais Brasileiros de Dermatologia 94:4, pages 462-469.
Crossref
Katerina M. Korch & Donald A. Watson. (2019) Cross-Coupling of Heteroatomic Electrophiles. Chemical Reviews 119:13, pages 8192-8228.
Crossref
Kristine Senkane, Ekaterina V. Vinogradova, Radu M. Suciu, Vincent M. Crowley, Balyn W. Zaro, J. Michael Bradshaw, Ken A. Brameld & Benjamin F. Cravatt. (2019) The Proteome‐Wide Potential for Reversible Covalency at Cysteine. Angewandte Chemie.
Crossref
João P. M. António, Roberto Russo, Cátia Parente Carvalho, Pedro M. S. D. Cal & Pedro M. P. Gois. (2019) Boronic acids as building blocks for the construction of therapeutically useful bioconjugates. Chemical Society Reviews 48:13, pages 3513-3536.
Crossref
Matthias Gehringer & Stefan A. Laufer. (2018) Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology. Journal of Medicinal Chemistry 62:12, pages 5673-5724.
Crossref
Collette S. Guy, Matthew I. Gibson & Elizabeth Fullam. (2019) Targeting extracellular glycans: tuning multimeric boronic acids for pathogen-selective killing of Mycobacterium tuberculosis . Chemical Science 10:23, pages 5935-5942.
Crossref
Phil Servatius, Tanja Stach & Uli Kazmaier. (2019) Total Synthesis of Luminmycin A, a Cryptic Natural Product from Photorhabdus Luminescens . European Journal of Organic Chemistry 2019:20, pages 3163-3168.
Crossref
B. Marco-Dufort & M.W. Tibbitt. (2019) Design of moldable hydrogels for biomedical applications using dynamic covalent boronic esters. Materials Today Chemistry 12, pages 16-33.
Crossref
Hong Chen, Feihong Chen, Sinan Pei & Shaohua Gou. (2019) Pomalidomide hybrids act as proteolysis targeting chimeras: Synthesis, anticancer activity and B-Raf degradation. Bioorganic Chemistry 87, pages 191-199.
Crossref
Brian Foo, Camille Barbier, Kevin Guo, Jaminie Vasantharuban, Gergely L. Lukacs & Alvin Shrier. (2019) Mutation-specific peripheral and ER quality control of hERG channel cell-surface expression. Scientific Reports 9:1.
Crossref
Mengdie Wang, James P. Hinton, Jaime M. C. Gard, Joe G. N. Garcia, Beatrice S. Knudsen, Raymond B. Nagle & Anne E. Cress. (2019) Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell–cell and cell–extracellular matrix interactions. Molecular Biology of the Cell 30:7, pages 838-850.
Crossref
V. B. Sokolov & A. Yu. Aksinenko. (2019) Methyl Trifluoropyruvate Pyrazin-2-ylimine in Cyclocondensation and Cycloaddition Reactions. Russian Journal of General Chemistry 89:2, pages 364-367.
Crossref
Maoyuan Tian, Taoling Zeng, Mingdong Liu, Shang Han, Huayue Lin, Qi Lin, Li Li, Tingting Jiang, Gao Li, Hong Lin, Ting Zhang, Qiaofeng Kang, Xianming Deng & Hong-Rui Wang. (2019) A cell-based high-throughput screening method based on a ubiquitin-reference technique for identifying modulators of E3 ligases. Journal of Biological Chemistry 294:8, pages 2880-5770.
Crossref
Robert M. Rifkin, Rohan Medhekar, E. Susan Amirian, Kathleen M. Aguilar, Thomas Wilson, Marley Boyd, Khalid Mezzi & Sumeet Panjabi. (2019) A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting. Therapeutic Advances in Hematology 10, pages 204062071881669.
Crossref
Marcus J.C. Long, Ann P. Lawson, Rick Baggio, Yu Qian, Lior Rozhansky, Domenico Fasci, Farid El Oualid, Eranthie Weerapana & Lizbeth Hedstrom. (2019) Diarylcarbonates are a new class of deubiquitinating enzyme inhibitor. Bioorganic & Medicinal Chemistry Letters 29:2, pages 204-211.
Crossref
R. M. Anthony & A. L. Den Hertog. (2018) PYRAZINAMIDE/PYRAZINOIC ACID RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS: RECENT FINDINGS AND IMPLICATIONS FOR IMPROVING THE TREATMENT OF TUBERCULOSIS. Russian Journal of Infection and Immunity 8:4, pages 425-434.
Crossref
Rieko Oyama, Fusako Kito, Zhiwei Qiao, Marimu Sakumoto, Rei Noguchi, Mami Takahashi, Shunichi Toki, Yoshikazu Tanzawa, Akihiko Yoshida, Akira Kawai & Tadashi Kondo. (2018) Establishment of a novel patient-derived Ewing’s sarcoma cell line, NCC-ES1-C1. In Vitro Cellular & Developmental Biology - Animal 54:10, pages 770-778.
Crossref
Jie Li, Xuewen Du, Devon J. Powell, Rong Zhou, Junfeng Shi, Hongjian He, Zhaoqianqi Feng & Bing Xu. (2018) Down‐regulating Proteolysis to Enhance Anticancer Activity of Peptide Nanofibers. Chemistry – An Asian Journal 13:22, pages 3464-3468.
Crossref
C. Benjamin Schwamb, Keegan P. Fitzpatrick, Alexander C. Brueckner, H. Camille Richardson, Paul H.-Y. Cheong & Karl A. Scheidt. (2018) Enantioselective Synthesis of α-Amidoboronates Catalyzed by Planar-Chiral NHC-Cu(I) Complexes. Journal of the American Chemical Society 140:34, pages 10644-10648.
Crossref
Matthew C. White, Rebecca D. Schroeder, Keyi Zhu, Katherine Xiong & David J. McConkey. (2018) HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells. Oncogene 37:32, pages 4413-4427.
Crossref
Can Yang, Yuanyuan Xu, Kangping Xu, Guishan Tan & Xia Yu. (2018) Preparation of new halogenated diphenyl pyrazine analogs in Escherichia coli by a mono-module fungal nonribosomal peptide synthetase from Penicillium herquei. Tetrahedron Letters 59:32, pages 3084-3087.
Crossref
Peter Tsvetkov, Julia Adler, Nadav Myers, Assaf Biran, Nina Reuven & Yosef Shaul. (2018) Oncogenic addiction to high 26S proteasome level. Cell Death & Disease 9:7.
Crossref
Meera Patel, Paul G. Horgan, Donald C. McMillan & Joanne Edwards. (2018) NF-κB pathways in the development and progression of colorectal cancer. Translational Research 197, pages 43-56.
Crossref
Abdul-Malek S. Al-Tamimi, Y. Sheena Mary, Pankaj B. Miniyar, Lamya H. Al-Wahaibi, Ali A. El-Emam, Stevan Armaković & Sanja J. Armaković. (2018) Synthesis, spectroscopic analyses, chemical reactivity and molecular docking study and anti-tubercular activity of pyrazine and condensed oxadiazole derivatives. Journal of Molecular Structure 1164, pages 459-469.
Crossref
Eun Mi Lee & Bukyung Kim. (2018) Clinical significance of trabecular bone score for prediction of pathologic fracture risk in patients with multiple myeloma. Osteoporosis and Sarcopenia 4:2, pages 73-76.
Crossref
Barbara Kaltschmidt, Johannes Greiner, Hussamadin Kadhim & Christian Kaltschmidt. (2018) Subunit-Specific Role of NF-κB in Cancer. Biomedicines 6:2, pages 44.
Crossref
Safija Herenda, Jelena Ostojić, Edhem Hasković, Denis Hasković, Mladen Miloš & Borivoj Galić. (2018) Electrochemical Investigation of the Influence of K2[B3O3F4OH] on the Activity of Immobilized Superoxide Dismutase. International Journal of Electrochemical Science 13:4, pages 3279-3287.
Crossref
Christopher Chu, Eric W. Rudnick & Kiran Motaparthi. (2018) Blastic plasmacytoid dendritic cell neoplasm with centrocyte‐like morphology clinically simulating a melanocytic nevus. Journal of Cutaneous Pathology 45:4, pages 249-253.
Crossref
Jochen H. M. Prehn & Irene Llorente-Folch. 2018. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants. Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants 133 167 .
Caitlin M. O’Connor, Abbey Perl, Daniel Leonard, Jaya Sangodkar & Goutham Narla. (2018) Therapeutic targeting of PP2A. The International Journal of Biochemistry & Cell Biology 96, pages 182-193.
Crossref
Jie Zhou, Xuewen Du, Xiaoyi Chen, Jiaqing Wang, Ning Zhou, Difei Wu & Bing Xu. (2018) Enzymatic Self-Assembly Confers Exceptionally Strong Synergism with NF-κB Targeting for Selective Necroptosis of Cancer Cells. Journal of the American Chemical Society 140:6, pages 2301-2308.
Crossref
Hiroaki Sato, Kenshiro Matsuda, Yosuke Amagai, Akane Tanaka & Hiroshi Matsuda. (2018) Suppressive Effect of Bortezomib on LPS-Induced Inflammatory Responses in Horses. Journal of Equine Veterinary Science 61, pages 114-120.
Crossref
Nicolas Richy, Daad Sarraf, Xavier Maréchal, Naëla Janmamode, Rémy Le Guével, Emilie Genin, Michèle Reboud-Ravaux & Joëlle Vidal. (2018) Structure-based design of human immuno- and constitutive proteasomes inhibitors. European Journal of Medicinal Chemistry 145, pages 570-587.
Crossref
Elodie Bosc, Jhennifer Nastri, Valérie Lefort, Marilia Valli, Fernando Contiguiba, Renan Pioli, Maysa Furlan, Vanderlan da Silva Bolzani, Chahrazade El Amri & Michèle Reboud-Ravaux. (2018) Piperlongumine and some of its analogs inhibit selectively the human immunoproteasome over the constitutive proteasome. Biochemical and Biophysical Research Communications 496:3, pages 961-966.
Crossref
Shang-Yi Huang, Cheng-Shyong Chang, Ta-Chih Liu, Po-Nan Wang, Su-Peng Yeh, Ching-Liang Ho, Ming-Chung Kuo, Hsuan-Yu Lin, Jan de Jong, Jia-Yi Chen & Ya-Wen Yang. (2018) Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma. Hematological Oncology 36:1, pages 238-244.
Crossref
Kaicheng Li, Chelsea Weidman & Jianmin Gao. (2017) Dynamic Formation of Imidazolidino Boronate Enables Design of Cysteine-Responsive Peptides. Organic Letters 20:1, pages 20-23.
Crossref
Lili Chen, Jun-Jian Shen, Qian Gao & Senmiao Xu. (2018) Synthesis of cyclic chiral α-amino boronates by copper-catalyzed asymmetric dearomative borylation of indoles. Chemical Science 9:26, pages 5855-5859.
Crossref
Blake E. Daniels & Craig E. Stivala. (2018) A solid-phase approach for the synthesis of α-aminoboronic acid peptides. RSC Advances 8:6, pages 3343-3347.
Crossref
Piyush Kumar Verma, Mahadev L. Shegavi, Shubhankar Kumar Bose & K. Geetharani. (2018) A nano-catalytic approach for C–B bond formation reactions. Organic & Biomolecular Chemistry 16:6, pages 857-873.
Crossref
Eleni N. Tsakiri, Evangelos Terpos, Eleni-Dimitra Papanagnou, Efstathios Kastritis, Vincent Brieudes, Maria Halabalaki, Tina Bagratuni, Bogdan I. Florea, Herman S. Overkleeft, Luca Scorrano, Alexios-Leandros Skaltsounis, Meletios A. Dimopoulos & Ioannis P. Trougakos. (2017) Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events. Scientific Reports 7:1.
Crossref
Jonathan D. Wrigley, Gerald Gavory, Iain Simpson, Marian Preston, Helen Plant, Jenna Bradley, Anne U. Goeppert, Ewelina Rozycka, Gareth Davies, Jarrod Walsh, Andrea Valentine, Keeva McClelland, Krzysztofa Ewa Odrzywol, Jonathan Renshaw, Joanna Boros, Jonathan Tart, Lindsey Leach, Thorsten Nowak, Richard A. Ward, Timothy Harrison & David M. Andrews. (2017) Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily. ACS Chemical Biology 12:12, pages 3113-3125.
Crossref
Jae-Kwang Jung, Gi-Jeong Gwon, Sanjiv Neupane, Wern-Joo Sohn, Ki-Rim Kim, Ji-Youn Kim, Seo-Young An, Tae-Yub Kwon, Chang-Hyeon An, Youngkyun Lee, Jae-Young Kim & Jung-Hong Ha. (2017) Bortezomib Facilitates Reparative Dentin Formation after Pulp Access Cavity Preparation in Mouse Molar. Journal of Endodontics 43:12, pages 2041-2047.
Crossref
Anna A. Hovhannisyan, The Hien Pham, Dominique Bouvier, Xiao Tan, SiAmmar Touhar, Gevorg G. Mkryan, Ashot M. Dallakyan, Chahrazade El Amri, Gagik S. Melikyan, Michèle Reboud-Ravaux & Michelle Bouvier-Durand. (2017) Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits. Bioorganic & Medicinal Chemistry Letters 27:23, pages 5172-5178.
Crossref
Justyna Sidor-Kaczmarek, Mirosława Cichorek, Jan Henryk Spodnik, Sławomir Wójcik & Janusz Moryś. (2017) Proteasome inhibitors against amelanotic melanoma. Cell Biology and Toxicology 33:6, pages 557-573.
Crossref
Claire L. Soave, Tracey Guerin, Jinbao Liu & Q. Ping Dou. (2017) Targeting the ubiquitin-proteasome system for cancer treatment: discovering novel inhibitors from nature and drug repurposing. Cancer and Metastasis Reviews 36:4, pages 717-736.
Crossref
Claudiu T. Supuran. (2017) Bortezomib inhibits mammalian carbonic anhydrases. Bioorganic & Medicinal Chemistry 25:19, pages 5064-5067.
Crossref
D. V. R. Venugopal, Amperayani Karteek Rao, Parimi Uma Devi, Y. N. Sastry, K. Aruna Lakshmi, M. Tarak Ramji & Y. Shiralgi. (2017) Design, synthesis and characterization of peptidyl boronate analogues as effective antimicrobial agents. Research on Chemical Intermediates 43:10, pages 5755-5778.
Crossref
Tianyi ZhangFu-Ning Hsu, Xiao-Jun Xie, Xiao Li, Mengmeng Liu, Xinsheng Gao, Xun PeiYang LiaoWei DuJun-Yuan Ji. (2017) Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids. Proceedings of the National Academy of Sciences 114:36.
Crossref
Jannick Clemens, Lukas Welti, Julia Schäfer, Anja Seckinger, Jürgen Burhenne, Dirk Theile & Johanna Weiss. (2017) Bortezomib, carfilzomib and ixazomib do not mediate relevant transporter-based drug-drug interactions. Oncology Letters 14:3, pages 3185-3192.
Crossref
Christian Setz, Melanie Friedrich, Pia Rauch, Kirsten Fraedrich, Alina Matthaei, Maximilian Traxdorf & Ulrich Schubert. (2017) Inhibitors of Deubiquitinating Enzymes Block HIV-1 Replication and Augment the Presentation of Gag-Derived MHC-I Epitopes. Viruses 9:8, pages 222.
Crossref
Lili Chen, Xiaoliang Zou, Haonan Zhao & Senmiao Xu. (2017) Copper-Catalyzed Asymmetric Protoboration of β-Amidoacrylonitriles and β-Amidoacrylate Esters: An Efficient Approach to Functionalized Chiral α-Amino Boronate Esters. Organic Letters 19:13, pages 3676-3679.
Crossref
Lili Wang, Changying Shi, Forrest A. Wright, Dandan Guo, Xu Wang, Dongliang Wang, Richard J.H. Wojcikiewicz & Juntao Luo. (2017) Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment. Cancer Research 77:12, pages 3293-3305.
Crossref
Stewart Sell. (2017) Cancer immunotherapy: Breakthrough or “deja vu, all over again”?. Tumor Biology 39:6, pages 101042831770776.
Crossref
Lin JiangJinlin SongXiaolei HuHongmei ZhangEnyi HuangYan ZhangFeng DengXiaomian Wu. (2017) The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats. Journal of Periodontology 88:5, pages 473-483.
Crossref
Danielle A. Jandial, William E. Brady, Stephen B. Howell, Heather A. Lankes, Russell J. Schilder, Jan H. Beumer, Susan M. Christner, Sandra Strychor, Matthew A. Powell, Andrea R. Hagemann, Kathleen N. Moore, Joan L. Walker, Paul A. DiSilvestro, Linda R. Duska, Paula M. Fracasso & Don S. Dizon. (2017) A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology 145:2, pages 236-242.
Crossref
Tingting Lu, Ming Gu, Yan Zhao, Xinyu Zheng & Chengzhong Xing. (2017) Autophagy contributes to falcarindiol-induced cell death in breast cancer cells with enhanced endoplasmic reticulum stress. PLOS ONE 12:4, pages e0176348.
Crossref
A Suares, M Mori Sequeiros Garcia, C Paz & V González-Pardo. (2017) Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma. Cellular Signalling 32, pages 124-132.
Crossref
Joseph D. Tariman. (2017) Changes in Cancer Treatment. Nursing Clinics of North America 52:1, pages 65-81.
Crossref
Bruno O. Villoutreix, Abdel-Majid Khatib, Yan Cheng, Maria A. Miteva, Xavier Maréchal, Joëlle Vidal & Michèle Reboud-Ravaux. (2017) Blockade of the malignant phenotype by β -subunit selective noncovalent inhibition of immuno- and constitutive proteasomes . Oncotarget 8:6, pages 10437-10449.
Crossref
Antigoni Kotali, Anna Maniadaki, Elvira Kotali, Philip A. Harris, Ewa Różycka-Sokołowska, Piotr Bałczewski & John A. Joule. (2017) New tetrahedral boron heterobicycles: Cyclocondensation of phenylboronic acid with β-keto butanoic acid N-acyl hydrazones. Tetrahedron Letters 58:6, pages 512-515.
Crossref
J. Brus, J. Czernek, M. Urbanova, L. Kobera & A. Jegorov. (2017) An efficient 2D 11 B– 11 B solid-state NMR spectroscopy strategy for monitoring covalent self-assembly of boronic acid-derived compounds: the transformation and unique architecture of bortezomib molecules in the solid state . Physical Chemistry Chemical Physics 19:1, pages 487-495.
Crossref
Suman De Sarkar, N. Y. Phani Kumar & Lutz Ackermann. (2017) Ruthenium(II) Biscarboxylate-Catalyzed Borylations of C(sp 2 )−H and C(sp 3 )−H Bonds . Chemistry - A European Journal 23:1, pages 84-87.
Crossref
Shyam Ramachandran, Samantha R. Osterhaus, Kalpaj R. Parekh, Ashley M. Jacobi, Mark A. Behlke & Paul B. McCrayJr.Jr.. (2016) SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation. Journal of Biological Chemistry 291:49, pages 25489-25504.
Crossref
Jiong Zhang, Fei Yang, Zhitao Qiao, Mingyan Zhu & Huchen Zhou. (2016) Chalcone–benzoxaborole hybrids as novel anticancer agents. Bioorganic & Medicinal Chemistry Letters 26:23, pages 5797-5801.
Crossref
Jiali Jin, Jian Liu, Cong Chen, Zhenping Liu, Cong Jiang, Hongshang Chu, Weijuan Pan, Xinbo Wang, Lingqiang Zhang, Bin Li, Cizhong Jiang, Xin Ge, Xin Xie & Ping Wang. (2016) The deubiquitinase USP21 maintains the stemness of mouse embryonic stem cells via stabilization of Nanog. Nature Communications 7:1.
Crossref
Mindy I. Davis, Rajan Pragani, Jennifer T. Fox, Min Shen, Kalindi Parmar, Emily F. Gaudiano, Li Liu, Cordelle Tanega, Lauren McGee, Matthew D. Hall, Crystal McKnight, Paul Shinn, Henrike Nelson, Debasish Chattopadhyay, Alan D. D'Andrea, Douglas S. Auld, Larry J. DeLucas, Zhuyin Li, Matthew B. Boxer & Anton Simeonov. (2016) Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models. Journal of Biological Chemistry 291:47, pages 24628-24640.
Crossref
Anita Schlierf, Eva Altmann, Jean Quancard, Anne B. Jefferson, René Assenberg, Martin Renatus, Matthew Jones, Ulrich Hassiepen, Michael Schaefer, Michael Kiffe, Andreas Weiss, Christian Wiesmann, Richard Sedrani, Jörg Eder & Bruno Martoglio. (2016) Targeted inhibition of the COP9 signalosome for treatment of cancer. Nature Communications 7:1.
Crossref
Hamid Reza Masoodi, Sotoodeh Bagheri, Samira Saeednia, Marziyeh Mohammadi & Ali Reza Raeisipoor. (2016) The influence of substituents on cooperativity between CH···π and N···H hydrogen bonds in a T-shaped configuration: X-benzene⊥(FH···pyrazine···HF) complexes as a working model. Structural Chemistry 27:5, pages 1521-1530.
Crossref
Pinchas Zer?Aviv, Moran Shubely, Yoni Moskovits, Olga Viskind, Amnon Albeck, Didier Vertommen, Sharon Ruthstein, Michael Shokhen & Arie Gruzman. (2016) A New Oxopiperazin-Based Peptidomimetic Molecule Inhibits Prostatic Acid Phosphatase Secretion and Induces Prostate Cancer Cell Apoptosis. ChemistrySelect 1:15, pages 4658-4667.
Crossref
Claudiu T. Supuran. (2016) Bortezomib inhibits bacterial and fungal β-carbonic anhydrases. Bioorganic & Medicinal Chemistry 24:18, pages 4406-4409.
Crossref
Yuchen Zhang, Junjun Cheng, Junmeng Zhang, Xiaofan Wu, Fang Chen, Xuejun Ren, Yunlong Wang, Quan Li & Yu Li. (2016) Proteasome inhibitor PS-341 limits macrophage necroptosis by promoting cIAPs-mediated inhibition of RIP1 and RIP3 activation. Biochemical and Biophysical Research Communications 477:4, pages 761-767.
Crossref
Rachel Raynes, Laura C.D. Pomatto & Kelvin J.A. Davies. (2016) Degradation of oxidized proteins by the proteasome: Distinguishing between the 20S, 26S, and immunoproteasome proteolytic pathways. Molecular Aspects of Medicine 50, pages 41-55.
Crossref
Xian Fu, Rui Liu, Iona Sanchez, Cecilia Silva-Sanchez, Nathaniel L. Hepowit, Shiyun Cao, Sixue Chen & Julie Maupin-Furlow. (2016) Ubiquitin-Like Proteasome System Represents a Eukaryotic-Like Pathway for Targeted Proteolysis in Archaea. mBio 7:3.
Crossref
M Alexander, J King, S Lingaratnam, J Byrne, K MacMillan, A Mollo, S Kirsa & M Green. (2014) A survey of manufacturing and handling practices for monoclonal antibodies by pharmacy, nursing and medical personnel. Journal of Oncology Pharmacy Practice 22:2, pages 219-227.
Crossref
A. L. Furfaro, S. Piras, C. Domenicotti, D. Fenoglio, A. De Luigi, M. Salmona, L. Moretta, U. M. Marinari, M. A. Pronzato, N. Traverso & M. Nitti. (2016) Role of Nrf2, HO-1 and GSH in Neuroblastoma Cell Resistance to Bortezomib. PLOS ONE 11:3, pages e0152465.
Crossref
Julie King, Marliese Alexander, Jenny Byrne, Kent MacMillan, Adele Mollo, Sue Kirsa & Michael Green. (2014) A review of the evidence for occupational exposure risks to novel anticancer agents ? A focus on monoclonal antibodies. Journal of Oncology Pharmacy Practice 22:1, pages 121-134.
Crossref
Paweł ŚledźWolfgang Baumeister. (2016) Structure-Driven Developments of 26S Proteasome Inhibitors. Annual Review of Pharmacology and Toxicology 56:1, pages 191-209.
Crossref
Isidro Cortés-Ciriano, Gerard J. P. van Westen, Guillaume Bouvier, Michael Nilges, John P. Overington, Andreas Bender & Thérèse E. Malliavin. (2016) Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel. Bioinformatics 32:1, pages 85-95.
Crossref
Vincenzo Alterio, Roberta Cadoni, Davide Esposito, Daniela Vullo, Anna Di Fiore, Simona Maria Monti, Andrea Caporale, Menotti Ruvo, Mario Sechi, Pascal Dumy, Claudiu T. Supuran, Giuseppina De Simone & Jean-Yves Winum. (2016) Benzoxaborole as a new chemotype for carbonic anhydrase inhibition. Chemical Communications 52:80, pages 11983-11986.
Crossref
Hao-Ping Fang, Chia-Chieh Fu, Chin-Kuen Tai, Ken-Hao Chang, Ru-Han Yang, Meng-Ju Wu, Hsien-Chi Chen, Chia-Jung Li, Shi-Qing Huang, Wan-Hsiang Lien, Chih-Hsin Chen, Chung-Hung Hsieh, Bo-Cheng Wang, Siu-Fung Cheung & Po-Shen Pan. (2016) Synthesis and stability study of isocyano aryl boronate esters and their synthetic applications. RSC Advances 6:36, pages 30362-30371.
Crossref
Xinyu Wang, Changping Wang, Qiang Zhang & Yiyun Cheng. (2016) Near infrared light-responsive and injectable supramolecular hydrogels for on-demand drug delivery. Chemical Communications 52:5, pages 978-981.
Crossref
Jorge Cruz‐Huerta, Gonzalo Campillo‐Alvarado, Herbert Höpfl, Patricia Rodríguez‐Cuamatzi, Viviana Reyes‐Márquez, Jorge Guerrero‐Álvarez, Domingo Salazar‐Mendoza & Norberto Farfán‐García. (2015) Self‐Assembly of Triphenylboroxine and the Phenylboronic Ester of Pentaerythritol with Piperazine, trans ‐1,4‐Diaminocyclohexane, and 4‐Aminopyridine . European Journal of Inorganic Chemistry 2016:3, pages 355-365.
Crossref
Jerry Vriend, Saeid Ghavami & Hassan Marzban. (2015) The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma. Molecular Brain 8:1.
Crossref
Ramzi M. Mohammad, Irfana Muqbil, Leroy Lowe, Clement Yedjou, Hsue-Yin Hsu, Liang-Tzung Lin, Markus David Siegelin, Carmela Fimognari, Nagi B. Kumar, Q. Ping Dou, Huanjie Yang, Abbas K. Samadi, Gian Luigi Russo, Carmela Spagnuolo, Swapan K. Ray, Mrinmay Chakrabarti, James D. Morre, Helen M. Coley, Kanya Honoki, Hiromasa Fujii, Alexandros G. Georgakilas, Amedeo Amedei, Elena Niccolai, Amr Amin, S. Salman Ashraf, William G. Helferich, Xujuan Yang, Chandra S. Boosani, Gunjan Guha, Dipita Bhakta, Maria Rosa Ciriolo, Katia Aquilano, Sophie Chen, Sulma I. Mohammed, W. Nicol Keith, Alan Bilsland, Dorota Halicka, Somaira Nowsheen & Asfar S. Azmi. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology 35, pages S78-S103.
Crossref
Maria Cosenza, Monica Civallero, Samantha Pozzi, Luigi Marcheselli, Alessia Bari & Stefano Sacchi. (2015) The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines. Hematological Oncology 33:4, pages 166-175.
Crossref
Tingting Li, Shengbin Zhou, Jiang Wang, José Luis Aceña, Vadim A. Soloshonok & Hong Liu. (2015) Asymmetric Synthesis of (2 S ,3 S )-α-(1-Oxoisoindolin-3-yl)glycines under Low-Basicity “Kinetic” Control . The Journal of Organic Chemistry 80:22, pages 11275-11280.
Crossref

Displaying 200 of 493 citing articles. Use the download link below to view the full list of citing articles.

Download full citations list

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.